Works about PERAMPANEL
Results: 125
Effectiveness and safety of Perampanel in refractory status epilepticus: a case series.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 2, p. 879, doi. 10.1007/s10072-024-07798-w
- By:
- Publication type:
- Article
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2943, doi. 10.1007/s10072-023-06803-y
- By:
- Publication type:
- Article
Efficacy and tolerability of perampanel in a patient with Late-Onset myoclonic epilepsy in Down syndrome (LOMEDS): a case report.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 2, p. 757, doi. 10.1007/s10072-022-06452-7
- By:
- Publication type:
- Article
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1389, doi. 10.1007/s10072-020-04636-7
- By:
- Publication type:
- Article
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 2, p. 326, doi. 10.3390/brainsci13020326
- By:
- Publication type:
- Article
Effects of Vagus Nerve Stimulation following Corpus Callosotomy for Patients with Drug-Resistant Epilepsy.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 11, p. 1395, doi. 10.3390/brainsci11111395
- By:
- Publication type:
- Article
The Cognitive and Behavioural Effects of Perampanel in Children with Neurodevelopmental Disorders: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 372, doi. 10.3390/jcm13020372
- By:
- Publication type:
- Article
Replacement of Valproic Acid with New Anti-Seizure Medications in Idiopathic Generalized Epilepsy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4582, doi. 10.3390/jcm11154582
- By:
- Publication type:
- Article
Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 651, doi. 10.3390/biomedicines11030651
- By:
- Publication type:
- Article
Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3043, doi. 10.3390/biomedicines10123043
- By:
- Publication type:
- Article
Development and Bioanalytical Validation of RP-HPLC Method for the Simultaneous Determination of Perampanel and Carbamazepine in Human Plasma for Therapeutic Drug Monitoring.
- Published in:
- Journal of Analytical Chemistry, 2023, v. 78, n. 5, p. 622, doi. 10.1134/S1061934823050076
- By:
- Publication type:
- Article
Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1418609
- By:
- Publication type:
- Article
Switching from zonisamide to perampanel improved the frequency of seizures caused by hyperthermia in Dravet syndrome: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A multi-center, open-label, randomized clinical trial evaluating the preventive effect of perampanel on craniotomy-induced epileptogenesis in seizure-naive patients with supratentorial brain tumors: study protocol for a GRAMPAS trial.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-08693-7
- By:
- Publication type:
- Article
Clinical effects and outcomes of perampanel overdoses reported to U.S. poison centers.
- Published in:
- Clinical Toxicology (15563650), 2022, v. 60, n. 2, p. 239, doi. 10.1080/15563650.2021.1945083
- By:
- Publication type:
- Article
Is adjunctive perampanel beneficial for Lafora disease?
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2020, v. 77, n. 5, p. 539, doi. 10.2298/VSP170416013S
- By:
- Publication type:
- Article
Perampanel in chronic insomnia. A case control study of 33 patients.
- Published in:
- European Psychiatry, 2020, v. 63, p. S260
- By:
- Publication type:
- Article
Perampanel attenuates oxidative stress and pyroptosis following subarachnoid hemorrhage via the SIRT3/FOXO3α pathway.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48802-1
- By:
- Publication type:
- Article
Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40594-8
- By:
- Publication type:
- Article
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 8, p. 1200, doi. 10.3390/cells12081200
- By:
- Publication type:
- Article
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1209815
- By:
- Publication type:
- Article
Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1295784
- Publication type:
- Article
Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1189058
- By:
- Publication type:
- Article
Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1189058
- By:
- Publication type:
- Article
Successful Treatment of Drug-Resistant Seizures Secondary to Ring 20 Mosaicism with Perampanel as an Add-On Antiepileptic Drug.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Infection-Induced Elevated Plasma Perampanel in a Patient with Hemimegalencephaly.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis.
- Published in:
- CNS Drugs, 2023, v. 37, n. 10, p. 883, doi. 10.1007/s40263-023-01029-0
- By:
- Publication type:
- Article
Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures.
- Published in:
- 2021
- By:
- Publication type:
- research
Successful case of Lance-Adams syndrome treatment with early use of perampanel after targeted therapeutic hypothermia.
- Published in:
- Neurology Asia, 2023, v. 28, n. 2, p. 445, doi. 10.54029/2023uax
- By:
- Publication type:
- Article
Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2020.598266
- By:
- Publication type:
- Article
Perampanel's forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04490-z
- By:
- Publication type:
- Article
Stability Indicating Methods for Determination of Third Generation Antiepileptic Drugs and Their Related Substances.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.
- Published in:
- Archives of Toxicology, 2021, v. 95, n. 7, p. 2459, doi. 10.1007/s00204-021-03053-9
- By:
- Publication type:
- Article
Perampanel markedly improved clinical seizures in a patient with a Rett‐like phenotype and 960‐kb deletion on chromosome 9q34.11 including the STXBP1.
- Published in:
- Clinical Case Reports, 2022, v. 10, n. 5, p. 1, doi. 10.1002/ccr3.5811
- By:
- Publication type:
- Article
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes.
- Published in:
- Frontiers in Genetics, 2023, p. 01, doi. 10.3389/fgene.2023.1215493
- By:
- Publication type:
- Article
Efficacy of Perampanel in Nocturnal Seizures in Adult Patients with Epilepsy.
- Published in:
- Acta Neurologica Scandinavica, 2024, v. 2024, p. 1, doi. 10.1155/2024/5534808
- By:
- Publication type:
- Article
Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice.
- Published in:
- Acta Neurologica Scandinavica, 2023, p. 1, doi. 10.1155/2023/2852853
- By:
- Publication type:
- Article
European perspective of perampanel response in people with Intellectual Disability.
- Published in:
- Acta Neurologica Scandinavica, 2020, v. 142, n. 3, p. 255, doi. 10.1111/ane.13261
- By:
- Publication type:
- Article
Changes in perampanel levels during de‐induction: Simulations following carbamazepine discontinuation.
- Published in:
- Acta Neurologica Scandinavica, 2020, v. 142, n. 2, p. 131, doi. 10.1111/ane.13286
- By:
- Publication type:
- Article
First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study.
- Published in:
- Acta Neurologica Scandinavica, 2020, v. 141, n. 2, p. 132, doi. 10.1111/ane.13197
- By:
- Publication type:
- Article
A 3.5-year clinical experience with perampanel for refractory epilepsy.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 5, p. 2084
- By:
- Publication type:
- Article
Efficacy and safety of perampanel for epilepsy: a systematic review and meta-analysis of real-world studies.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 13, p. 6027
- By:
- Publication type:
- Article
Anti-tumor effects of perampanel in malignant glioma cells.
- Published in:
- Oncology Letters, 2022, v. 24, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13541
- By:
- Publication type:
- Article
Optimizing perampanel monotherapy for surgically resected brain tumors.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2740
- By:
- Publication type:
- Article
Perampanel in brain tumor‐related epilepsy: Observational pilot study.
- Published in:
- Brain & Behavior, 2020, v. 10, n. 6, p. 1, doi. 10.1002/brb3.1612
- By:
- Publication type:
- Article
ALSUntangled 48: Perampanel (Fycompa).
- Published in:
- Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2019, v. 20, n. 5/6, p. 453, doi. 10.1080/21678421.2019.1573850
- By:
- Publication type:
- Article
Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 3, p. 825, doi. 10.1007/s40120-024-00618-5
- By:
- Publication type:
- Article
Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1236046
- By:
- Publication type:
- Article
Case report: Off-label use of low-dose perampanel in a 25-month-old girl with a pathogenic SYNGAP1 variant.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1221161
- By:
- Publication type:
- Article
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1182304
- By:
- Publication type:
- Article